Many startups make the mistake of viewing regulatory affairs – and regulators – as a necessary evil, or barrier to market entry. That can be a huge red flag to investors who know the value of using regulatory as a business and competitive strategy.

October 7, 2019
By Michelle Lott
Many startups make the mistake of viewing regulatory affairs – and regulators – as a necessary evil, or barrier to market entry. That can be a huge red flag to investors who know the value of using regulatory as a business and competitive strategy.
So You Want to be a Regulatory Consultant?
Then you will want to check out my interview with Elena Kyria on the Career Diaries podcast. We discussed the details
Learn MoreWhat Investors Need to Know About Start-Ups
Startups have different challenges along the road to market release than do the larger, established medical device organizations. As an
Learn MoreMaking the Business Case for MDR (or Whether It’s Worth Selling in Europe)
(Edited Transcript – link to the full presentation) How do you make the business case for MDR? You need
Learn More